Cancer Organoids as reliable disease models to drive clinical development of novel therapies

被引：2

作者：

Giovanni Blandino ^{[1
]}

Ronit Satchi-Fainaro ^{[2
]}

Ingeborg Tinhofer ^{[3
]}

Giovanni Tonon ^{[4
]}

Sarah C. Heilshorn ^{[5
]}

Yong-Jun Kwon ^{[6
]}

Ana Pestana ^{[3
]}

Carlotta Frascolla ^{[1
]}

Luca Pompili ^{[1
]}

Aurora Puce ^{[7
]}

Sara Iachettini ^{[1
]}

Annalisa Tocci ^{[8
]}

Sofia Karkampouna ^{[9
]}

Marianna Kruithof-de Julio ^{[9
]}

Piera Tocci ^{[10
]}

Nicla Porciello ^{[8
]}

Klizia Maccaroni ^{[7
]}

Daniela Rutigliano ^{[1
]}

Xiling Shen ^{[11
]}

Gennaro Ciliberto ^{[12
]}

机构：

[1] IRCCS Regina Elena National Cancer Institute,Translational Research Unit

[2] Tel Aviv University,Deapartment of Physiology and Pharmacology

[3] Charité University Medicin,Department of Radiooncology and Radiotherapy

[4] IRCCS San Raffaele Scientific Institute,Center of Omics Sciences

[5] Stanford University,Department of Materials Science and Engineering

[6] Luxembourg Institute of Health,Cellular Network and Molecular Therapeutic Target Unit

[7] IRCCS Regina Elena National Cancer Institute,Tumor of Immunology and Immunotherapy Unit

[8] IRCCS Regina Elena National Cancer Institute,Department for BioMedical Research

[9] University of Bern,Unit of Preclinical Models and New Therapeutic Agents

[10] IRCCS Regina Elena National Cancer Institute,GI Medical Oncology

[11] MD Anderson Cancer Center,Scientific Direction

[12] Terasaki Institute of Biomedical Innovation,undefined

[13] IRCCS Regina Elena National Cancer Institute,undefined

来源：

Journal of Experimental & Clinical Cancer Research | / 43卷 / 1期

关键词：

Organoid; Precision medicine; Patient-derived 3D culture model; Targeted therapy; Preclinical models; Cancer spheroid;

D O I：

10.1186/s13046-024-03258-7

中图分类号：

学科分类号：

摘要：

On September 23–24 (2024) the 6th Workshop IRE on Translational Oncology, titled “Cancer Organoids as Reliable Disease Models to Drive Clinical Development of Novel Therapies,” took place at the IRCCS Regina Elena Cancer Institute in Rome. This prominent international conference focused on tumor organoids, bringing together leading experts from around the world.

引用

共 50 条

[1] Development of Novel Therapies in Murine Models for Gaucher Disease
Enquist, Ida Berglin
Nilsson, Eva
Lo Bianco, Christophe
Mansson, Jan-Eric
Ehinger, Mats
Brady, Roscoe O.
Richter, Johan
Karlsson, Stefan
CLINICAL THERAPEUTICS, 2009, 31 : S198 - S199
[2] Development of Novel Therapies in Murine Models for Gaucher Disease
Karlsson, Stefan
HUMAN GENE THERAPY, 2010, 21 (04) : 490 - 491
[3] Heart organoids and tissue models for modeling development and disease
Miyamoto, Matthew
Nam, Lucy
Kannan, Suraj
Kwon, Chulan
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2021, 118 : 119 - 128
[4] Human Kidney Organoids: Nephron Models of Development and Disease
Valerius, M. Todd
TRANSPLANTATION, 2016, 100 (06) : 1171 - 1172
[5] Lupus: Novel therapies in clinical development
Chugh, Preeta Kaur
EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2012, 23 (03) : 212 - 218
[6] Functional Models of Parkinson's Disease: A Valuable Tool in the Development of Novel Therapies
Jenner, Peter
ANNALS OF NEUROLOGY, 2008, 64 (06) : S16 - S29
[7] Novel therapies for the treatment of prostate cancer: current clinical trials and development strategies
Morris, MJ
Scher, HI
SURGICAL ONCOLOGY-OXFORD, 2002, 11 (1-2): : 13 - 23
[8] Development of novel therapies for MG: Studies in animal models
Souroujon, M. C.
Brenner, T.
Fuchs, S.
AUTOIMMUNITY, 2010, 43 (5-6) : 446 - 460
[9] Novel treatments and therapies in development for pancreatic cancer
Günzburg, WH
Löhr, M
Salmons, B
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (06) : 769 - 786
[10] Pluripotent stem cell-derived retinal organoids for disease modeling and development of therapies
Kruczek, Kamil
Swaroop, Anand
STEM CELLS, 2020, 38 (10) : 1206 - 1215

← 1 2 3 4 5 →